MedTrace Logo

Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24

NCT06166979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the scalp from a serum format in healthy adults.

Conditions

  • Microbial Colonization

Interventions

OTHER

Active Comparator: Study Group A: Blis Q24 Serum at higher dose

Active Comparator: Study Group A: Blis Q24 Serum at 1e8 cfu/ dose (Active)

OTHER

Active Comparator: Study Group B: Blis Q24 Serum at lower dose

Active Comparator: Study Group A: Blis Q24 Serum at 1e6 cfu/ dose (Active)

Sponsors & Collaborators

  • BLIS Technologies Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2024-02-25
Completion
2024-07-31

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06166979 on ClinicalTrials.gov